White K, Loughlin L, Maqbool Z, Nilsen M, McClure J, Dempsie Y, Baker AH, MacLean MR. Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH. Physiol Genomics 43: 417-437, 2011. First published February 8, 2011 doi:10.1152/physiolgenomics.00249.2010.-Pulmonary arterial hypertension (PAH) is up to threefold more prevalent in women than men. Female mice overexpressing the serotonin transporter (SERT; SERTϩ mice) exhibit PAH and exaggerated hypoxia-induced PAH, whereas male SERTϩ mice remain unaffected. To further investigate these sex differences, microarray analysis was performed in the pulmonary arteries of normoxic and chronically hypoxic female and male SERTϩ mice. Quantitative RT-PCR analysis was employed for validation of the microarray data. In relevant groups, immunoblotting was performed for genes of interest (CEBP␤, CYP1B1, and FOS). To translate clinical relevance to our findings, CEBP␤, CYP1B1, and FOS mRNA and protein expression was assessed in pulmonary artery smooth muscle cells (PASMCs) derived from idiopathic PAH (IPAH) patients and controls. In female SERTϩ mice, multiple pathways with relevance to PAH were altered. This was also observed in chronically hypoxic female SERTϩ mice. We selected 10 genes of interest for qRT-PCR analysis (FOS, CEBP␤, CYP1B1, MYL3, HAMP2, LTF, PLN, NPPA, UCP1, and C1S), and 100% concordance was reported. Protein expression of three selected genes, CEBP␤, CYP1B1, FOS, was also upregulated in female SERTϩ mice. Serotonin and 17␤-estradiol increased CEBP␤, CYP1B1, and FOS protein expression in PASMCs. In addition, CEBP␤, CYP1B1, and FOS mRNA and protein expression was also increased in PASMCs derived from IPAH patients. Here, we have identified a number of genes that may predispose female SERTϩ mice to PAH, and these findings may also be relevant to human PAH. pulmonary arterial hypertension; estrogen; CCAAT enhancer binding protein; cytochrome P450 1B1; c-FOS PULMONARY ARTERIAL HYPERTENSION (PAH) is characterized by both remodeling and vasoconstriction of the pulmonary vasculature. Mutations in the gene encoding for the bone morphogenetic protein receptor type-2 (BMPR-II) are the predominant genetic cause of heritable PAH (HPAH) (27). BMPR-II mutations have been described in up to 80% of HPAH and 20% of idiopathic PAH (IPAH) patients. Despite this, penetrance is relatively low in BMPR-II mutation carriers as Ͻ20% of those actually develop PAH (26). Therefore, it is recognized that "second hit" risk factors contribute to disease pathogenesis.
PULMONARY ARTERIAL HYPERTENSION (PAH) is characterized by both remodeling and vasoconstriction of the pulmonary vasculature. Mutations in the gene encoding for the bone morphogenetic protein receptor type-2 (BMPR-II) are the predominant genetic cause of heritable PAH (HPAH) (27) . BMPR-II mutations have been described in up to 80% of HPAH and 20% of idiopathic PAH (IPAH) patients. Despite this, penetrance is relatively low in BMPR-II mutation carriers as Ͻ20% of those actually develop PAH (26) . Therefore, it is recognized that "second hit" risk factors contribute to disease pathogenesis.
A sex bias exists for both HPAH and IPAH, with females up to threefold more likely to present with disease (16, 28, 43) .
Despite this, the underlying reasons for these sex differences remain obscure. Estrogens are one possible risk factor in PAH. The use of oral contraceptives has been associated with the development of PAH (23) . Genotyping studies have also revealed alterations in estrogen signaling in PAH. For example, female PAH patients exhibit increased expression levels of estrogen receptor-1, which is the gene encoding for estrogen receptor alpha, compared with unaffected females (30) . Decreased expression of the estrogen-metabolizing enzyme cytochrome P450 1B1 (CYP1B1), leading to impaired estrogen metabolism, has also been described in female BMPR-II mutated PAH patients compared with unaffected female BMPR-II carriers (2) .
Multiple studies have implicated serotonin in the pathobiology of PAH. In mice, peripheral serotonin synthesis is required for the development of both hypoxia-induced PAH (25) and dexfenfluramine-induced PAH (5) , whereas the exogenous administration of serotonin uncovers a PAH phenotype in BMPR-II mutant mice (20) . Mice overexpressing the SERT (SERTϩ mice) also develop PAH and exaggerated hypoxiainduced PAH (21) . Consistent with this, mice with targeted SERT overexpression in the PASMCs under the guidance of its own SM22 promoter also develop PAH and severe hypoxiainduced PAH (8) . SERT expression is increased in human pulmonary artery smooth muscle cells (PASMCs) derived from IPAH patients, and this increased expression mediates enhanced serotonin-induced proliferation in these cells (6) . Taken together, this evidence highlights the critical role of smooth muscle-SERT in mediating serotonin effects in experimental and human PAH.
In this study, we investigated genotypic differences in the development of PAH in SERTϩ mice. Female SERTϩ mice develop PAH and exaggerated hypoxia-induced PAH, whereas male SERTϩ mice remain unaffected compared with their respective wild-type (WT) controls. This was only apparent at 5 mo of age. This experimental model of PAH is the first to exhibit female susceptibility and may provide insight into the female bias observed in human PAH. To investigate genotypic changes associated with the development and progression of PAH, microarray analysis was performed in the pulmonary arteries of 2 mo old SERTϩ mice. Genes of interest were further assessed via quantitative RT-PCR and immunoblotting. With relevance to human PAH, this was also investigated in human PASMCs.
METHODS

Ethical information.
All animal procedures conform with the United Kingdom Animal Procedures Act (1986) and with the "Guide for the Care and Use of Laboratory Animals" published by the US National Institutes of Health (NIH publication no. 85-23, revised 1996) . Animal approval was granted by the University Committee Board. Experimental procedures using human PASMCs conform to the principles outlined in the Declaration of Helsinki.
SERTϩ mice. Female and male SERTϩ mice (2 and 5 mo of age) were generated as previously described (21) . Where appropriate, mice were exposed to 14 days of hypobaric hypoxia (equivalent to 10% O 2). Age-matched C57B/6JϫCBA littermate mice were studied as controls.
Hemodynamic measurements. Heart rate, right ventricular pressure, and systemic arterial pressure were measured and analyzed as previously described (17) . Briefly, right ventricular pressure was measured via transdiaphragmatic right heart catheterization and systemic arterial pressure was measured via cannulation of the left common carotid artery. Hemodynamic measurements from six to eight mice for each group were assessed.
Lung histology. Sagittal sections of lung were elastica-Van Gieson stained and microscopically assessed for the muscularization of pulmonary arteries (Ͻ80 m external diameter) in a blinded fashion as Fig. 1 . Right ventricular systolic pressure (RVSP, n ϭ 6 -8; A), pulmonary vascular remodeling (PVR, n ϭ 5; B), and right ventricular hypertrophy (RVH, n ϭ 6 -8; C) measurements in female wild-type (WT) and SERTϩ mice at 2 (2M) and 5 mo (5M) of age, in both normoxic and chronic hypoxia. In normoxia, no pulmonary arterial hypertension (PAH) phenotype was observed in 2 mo female SERTϩ mice, however, was apparent at 5 mo of age, as assessed by increased RVSP and PVR. Hypoxia-induced elevations of RVSP, PVR and RVH were observed in all groups; 5 mo old SERTϩ mice exhibit increased RVSP, PVR, and RVH. Data are expressed as means Ϯ SE and analyzed by 2-way ANOVA followed by Bonferroni's post hoc test. *P Ͻ 0.05, **P Ͻ 0.01, cf. normoxic mice; §P Ͻ 0.05, § §P Ͻ 0.01, cf. WT mice. Fig. 2 . RVSP (n ϭ 6 -8, A), PVR(n ϭ 5, B), and RVH (n ϭ 6 -8, C) measurements in male WT and SERTϩ mice at 2 (2M) and 5 mo (5M) of age, in both normoxic and chronic hypoxia. In both normoxia and chronic hypoxia, 2 and 5 mo old male SERTϩ mice exhibit similar RVSP, PVR, and RVH compared with their respective WT controls. Data are expressed as means Ϯ SE and analyzed by 2-way ANOVA followed by Bonferroni's post hoc test. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001 cf. normoxic mice.
previously described (17) . Remodeled arteries were confirmed by the presence of a double elastic laminae. Lung sections from five mice for each group were studied. Approximately 150 arteries from each lung section (ϳ750 arteries in total for each group) were assessed.
Right ventricular hypertrophy. Right ventricular hypertrophy (RVH) was assessed by weight measurement of the right ventricular free wall (RV) and left ventricle plus septum (LVϩS). The ratio expressed is RV/LVϩS. RVH measurements from six to eight mice for each group were assessed.
Human PASMCs. Human PASMCs were provided by Prof N. W. Morrell (University of Cambridge, Cambridge, UK). Briefly, PASMCs were derived from the pulmonary arteries (1-3 mm internal diameter) of three nonfamilial IPAH patients. PASMCs derived from macroscopically normal lung biopsies (pulmonary arteries, 1-3 mm Microarray analysis. Microarray analysis was performed in the pulmonary arteries of female and male WT and SERTϩ mice at 2 mo of age. To investigate the development and progression of PAH in SERTϩ mice we assessed genotypic differences at 2 mo of age, where no PAH phenotype was reported. One advantage to this is the exclusion of possible compensatory gene expression changes associated with end-stage PAH, which may be apparent in SERTϩ mice at 5 mo of age where a PAH phenotype is reported. This was also repeated in mice following exposure to chronic hypoxia. For the purpose of biological replicates, pulmonary arteries from individual mice were subject to microarray analysis (n ϭ 4 each group, total 32 microarrays, Accession number E-MTAB-455). Total RNA was extracted from the main, left, and right pulmonary arteries using the TissueLyser and RNeasy Fibrous Mini Kit (Qiagen). RNA was subjected to an additional DNase purification step to eliminate genomic DNA contamination (RNase-free DNase, Qiagen). RNA integrity and quantification were assessed using the NanoDrop ND-1000 Spectrophotometer (Nano-Drop Technologies, Wilmington, DE) and Agilent 2100 Bioanalyzer system (Agilent Technologies). Absorbance of the RNA samples was quantified at 260 and 280 nm, and the 260/280 ratio was calculated. All samples showed a 260/280 ratio Ն 1.9 and RNA integrity number Ն 8.0, which was indicative of RNA purity. Complementary RNA (cRNA) was synthesized from RNA using the Illumina TotalPrep RNA Amplification Kit (Applied Biosystems). Briefly, cDNA was synthesized from 200 ng RNA with a T7 oligo(dT) RNA polymerase promoter. After second-strand synthesis, in vitro transcription was performed resulting in the synthesis of biotin-labeled antisense cRNA. For microarray analysis, 750 ng cRNA was hybridized to the Illumina MouseRef-8 v1.1 Expression BeadChip using the Whole-Genome Expression Direct Hybridization Kit and scanning performed with a BeadStation 500GX (Illumina). Of the total probe-sets (ϳ25,600) in each microarray, at least 24,613 were detected in each of the 32 arrays performed. Data were analyzed with BeadStudio software (Illumina). Hybridization signal strength was normalized to the median array and expression levels determined Fig. 3 . Hierarchical cluster analysis of the differentially expressed genes in female and male WT and SERTϩ mice (A). Representation of the differentially expressed genes in female SERTϩ mice (B) and male SERTϩ mice (C), arranged by biological processes. using the Average Normalization Beadstudio algorithm. For identifying differentially expressed genes, the following parameters recommended by Illumina were used: P value Ͻ0.05, diff. score Ͼ15, average signal Ͼ100.
Quantitative real-time PCR. Quantitative real-time PCR (qRT-PCR) was employed for validation of the microarray data. Genespecific primers corresponding to the PCR targets were designed based on published sequences in GenBank using the primer 3 program and synthesized by IDT (Integrated DNA Technologies; supplementary table). 1 We confirmed the absence of nonspecific amplification by examining PCR products by agarose gel electrophoresis, ensuring amplification of single discrete bands with no primer-dimers. Realtime PCR was carried out in a DNA Engine OPTICON2 (MJ Research). Each reaction was performed according to the Brilliant II SYBRGreen PCR Master Mix (Agilent Technologies) protocol using 10 ng of RNA. Three replicates were performed for each sample plus template-free samples as negative controls. Cycling parameters consisted of an initial reverse transcription step for 30 min at 50°C, followed by a 10 min incubation at 95°C to fully activate the DNA polymerase and 40 amplification cycles at 95°C for 30 s, 56°C/58°C for 30 or 40 s, and 72°C for 30 s. Fluorescence measurements were assessed at the end of the annealing phase at 78, 82, and 86°C. The CT 1 The online version of this article contains supplemental material. values were determined using the Opticon2 software, and the total amount of RNA was normalized against ␤-actin. Data are expressed as fold-change. Western blotting. Immediately following death, the pulmonary arteries were snap-frozen in liquid N 2 and stored at Ϫ80°C until use. To obtain a sufficient concentration of protein for analysis, arteries from four mice were suspended in 250 l lysis buffer (50 mmol/l Tris pH 7.4, 1 mmol/l DTT, 1ϫ complete-protease inhibitor tablet; Roche Diagnostics, West Sussex, UK) and homogenized using a microrotary blade.
Human PASMCs (passage 3-5) were derived from both IPAH patients and control subjects and solubilized in RIPA buffer. Immunoblotting was performed as previously described (5) . Experiments were repeated in triplicate, and ␣-tubulin was used for protein loading control. Densitometrical analysis was performed using TotalLab TL100 software. Data are expressed as the ratio of protein density to ␣-tubulin density.
Statistical analysis. Data were analyzed by a two-way ANOVA followed by Bonferroni's post hoc test, one-way ANOVA followed by Dunnett's post hoc test or unpaired t-test as appropriate. Data are expressed as means Ϯ SE.
RESULTS
Assessment of PAH.
In normoxia, right ventricular systolic pressure (RVSP), pulmonary vascular remodeling (PVR, % remodeled vessels), and right ventricular hypertrophy (RVH) were similar in 2 mo old male and female WT and SERTϩ mice. However, at 5 mo of age female SERTϩ mice exhibited PAH, as assessed by increased RVSP and RVP (Fig. 1) , whereas male SERTϩ mice remained unaffected (Fig. 2) . Following exposure to chronic hypoxia, all groups developed hypoxia-induced PAH as assessed by significant increases in RVSP, PVR, and RVH. However, at 2 mo of age, chronically hypoxic female SERTϩ mice exhibited increased RVH compared with WT mice. Similarly, at 5 mo of age these mice exhibited increased RVSP, PVR and RVH compared with 5 mo WT mice. Exaggerated hypoxia-induced PAH was not apparent in male SERTϩ mice at 2 or 5 mo of age. There were no systemic effects reported in both female and male normoxic and chronically hypoxic SERTϩ mice compared with WT mice, as assessed by no changes in systemic arterial pressure or heart rate (data not shown).
Genotypic differences in SERTϩ mice. We were interested in exploring the genotypic differences associated with the development and progression of PAH in female SERTϩ mice. In total, we identified a total of 155 genes that were significantly (P Ͻ 0.05) differentially expressed in female SERTϩ mice compared with their WT controls; 71 genes show increased expression (Table 1) , while the remaining 84 genes show reduced expression (Table 2 ). To determine their biological relevance, we functionally categorized these genes by biological processes. A considerable number of these genes (Ͼ40%) were assigned to one or more biological processes, of which 15 categories were present in total (Fig. 3) . Specifically, a large number of these genes were assigned to biological functions with relevance to PAH. These included oxidationreduction, cell differentiation, regulation of transcription, apoptosis, muscle contraction, cellular calcium ion homeostasis, and glycolysis.
To further investigate the genotypic changes underlying these sex differences in SERTϩ mice, we also performed microarray analysis in the pulmonary arteries of male SERTϩ mice. We observed that a total of 148 genes were significantly differentially expressed in male SERTϩ mice compared with male WT mice. Of these, 110 genes were increased (Table 3) , whereas the remaining 38 genes were decreased (Table 4) . When categorized by biological processes, only 25% of these genes were assigned to biological function, and nine categories were represented in total.
Hierarchal cluster analysis between the four normoxic groups (258 genes in total) revealed distinct gene expression patterns between female SERTϩ and female WT that were not apparent in the identical male SERTϩ and WT comparison.
Genotypic differences in hypoxic SERTϩ mice. We were also interested in investigating the genotypic differences associated with exaggerated hypoxia-induced PAH in female SERTϩ mice. Following exposure to chronic hypoxia, female SERTϩ mice exhibited a greater than twofold increase in the number of differentially expressed genes compared against the identical normoxic comparison. In total, 316 genes were differentially expressed. We observed that 254 genes were increased (Table 5 ), while the remaining 62 genes showed decreased expression (Table 6 ). When arranged by biological processes, 53% of genes were assigned to a total of 26 distinct pathways. Moreover, a significant number of these dysregulated pathways observed in chronically hypoxic female SERTϩ mice have been previously associated with PAH including apoptosis, inflammation, transcription, and metabolism (Fig. 4) . In contrast, a large number of these changes were not apparent in hypoxic male SERTϩ mice. A total of 145 genes were differentially expressed in male SERTϩ mice, with 87 showing increased expression (Table 7 ) and 58 showing decreased expression (Table 8) . When categorized by biological processes, 42% of these genes were assigned a biological function; 12 categories were represented in total.
Hierarchal cluster analysis of the differentially expressed genes between the four hypoxic groups revealed distinct gene expression patterns which were unique to female SERTϩ mice. This may be critical to the exaggerated hypoxia-induced PAH phenotype observed in these mice.
Quantitative RT-PCR analysis. For validation of the microarray study, we employed qRT-PCR. To perform this, we selected three differentially expressed genes for each of the four group comparisons (Supplementary Table) . Our genes of interest were FOS, CEBP␤, CYP1B1, MYL3, HAMP2, LTF, PLN, NPPA, UCP1, and C1S. In concordance with our microarray data, expression of these genes was significantly altered in relevant groups (Fig. 5) . Of particular interest, qRT-PCR analysis confirmed that FOS, CEBP␤ and CYP1B1 were considerably up-regulated (4-, 20-, and 8-fold, respectively) in female SERTϩ mice.
CCAAT/enhancer-binding protein beta, CYP1B1, and c-FOS protein expression in female SERTϩ mice. To build on interesting gene expression differences observed in female SERTϩ mice, we investigated expression of CCAAT/enhancer-binding protein beta (C/EBP␤), CYP1B1, and FOS at protein level. In agreement with our qRT-PCR findings, protein expression of C/EBP␤, CYP1B1, and c-FOS were also upregulated in the pulmonary arteries of female SERTϩ mice (Fig. 6) .
Serotonin and 17␤-estradiol stimulate C/EBP␤, CYP1B1, and c-FOS expression in human PASMCs.
To determine if serotonin and 17␤-estradiol stimulate expression of C/EBP␤, CYP1B1, and c-FOS, we investigated expression of these in PASMCs following 24 h stimulation with serotonin and 17␤-estradiol. Stimulation with serotonin or 17␤-estradiol was sufficient to increase C/EBP␤, CYP1B1, and c-FOS expression in PASMCs (Fig. 7) .
C/EBP␤, CYP1B1, and c-FOS expression in IPAH PASMCs. To identify if these findings translate with relevance to human PAH, we investigated the expression of CEBP␤, CYP1B1, and FOS in PASMCs derived from IPAH patients. PASMCs from non-PAH donors were studied as controls. Interestingly, CEBP␤, CYP1B1, and FOS expression appeared significantly increased in mRNA extracted from IPAH PASMCs (Fig. 8) . Similarly, Western blot analysis confirmed that protein expression of C/EBP␤, CYP1B1, and c-FOS is also increased in IPAH PASMCs compared with control PASMCs. 
Continued
DISCUSSION
Despite increased mortality reported in men (15), the incidence of both IPAH and HPAH remains up to threefold more common in women. This is highlighted in recent epidemiological studies carried out in Scotland, France, and USA, where 60, 65, and 77% of the patients studied respectively were female (16, 28, 43) . Established experimental models of PAH have failed to provide insight into this increased occurrence. Paradoxically, several experimental models of PAH exhibit male susceptibility compared with their female counterparts (12, 24, 29, 34) . Here, we describe an experimental model of PAH that exhibits female susceptibility. Female SERTϩ mice develop PAH and exaggerated hypoxia-induced PAH, whereas male SERTϩ mice remain unaffected, when compared against their respective WT controls. We were interested in determining the genotypic differences associated with the development and progression of PAH in SERTϩ mice. To investigate this, microarray analysis was performed in the pulmonary arteries of SERTϩ mice at 2 mo of age, where no PAH phenotype is reported.
Through microarray analysis we have identified a large number of differentially expressed genes in the pulmonary arteries of SERTϩ mice. In total, we identified 155 genes changed in female SERTϩ mice, while 148 genes were changed in male SERTϩ mice. Heat map analysis identified gene expression changes in females that were not apparent in males. When assigned to biological processes, we also identified that Ͼ40% of the differentially expressed genes in female SERTϩ mice were directly involved in biological pathways. In total, 15 known biological pathways were dysregulated in female SERTϩ mice and included oxidation-reduction, cell differentiation, regulation of transcription, apoptosis, muscle contraction, cellular calcium ion homeostasis, and glycolysis.
This may be relevant to the development of PAH in SERTϩ mice, as dysregulation of these pathways has been previously implicated in the pathogenesis of PAH (33, 35) . Indeed, similar pathway changes have also been described in the lungs of VIPϪ/Ϫ mice (9) and BMPR-II mutant mice (40) . In contrast to female SERTϩ mice, only 25% of altered genes in male SERTϩ mice were associated with biological function and as a consequence resulted in the dysregulation of pathways to a much lesser extent.
In chronic hypoxia, there were also a large number of differentially expressed genes in SERTϩ mice compared with their respective WT controls. We observed a total of 316 genes altered in females, whereas less than half (154) of these were altered in males. In hypoxic female SERTϩ mice, 53% of genes were associated with biological function. Similar to the normoxic female comparison, altered genes were related to apoptotic, inflammatory, transcription, and metabolic processes, all of which are well-described in PAH (13) . In total, 26 biological pathways were identified as dysregulated. As expected, fewer genes were reported as changed in male SERTϩ mice. These differences may help explain the exaggerated hypoxia-induced PAH phenotype in female SERTϩ mice.
The female hormone 17␤-estradiol is one risk factor in PAH. Decreased expression of the 17␤-estradiol-metabolizing enzyme CYP1B1, resulting in altered estrogen metabolism, has been identified in female PAH patients harboring a BMPR-II mutation compared with unaffected female carriers (2). Multiple factors modulate the levels of estrogen-metabolizing enzymes in the liver and target tissues, and the biological effects of an estrogen will depend on the profile of metabolites formed and the biological activities of each of these metabolites (50) . 17␤-Estradiol is metabolized to both pro-and antiproliferative metabolites, and its effects will depend on its metabolism. 17␤-Estradiol can be converted to estrone and subsequently metabolized to 16␣-hydroxyestrone (16-OHE1) via CYP3A4. Or alternatively, 17␤-estradiol is metabolized to 2-hydroxyestradiol (2-OHE) via the estrogen-metabolizing enzymes CYP1A1/2 and to a lesser extent via CYP1B1 (10, 46). 2-OHE can itself be metabolized to 2-methoxyestradiol (2-ME) via catechol O-methyltransferase (COMT). Both 2-OHE and 2-ME have antiproliferative effects on cells (44), whereas 16␣-OHE1 stimulates proliferation by constitutively activating the estrogen receptor (39) . Metabolism of 17␤-estradiol will therefore be species, sex, and strain-dependent, and differential disruption in the balance of metabolites may therefore account for the differential effects of female hormones in different models of PAH. Consistent with this, our microarray findings show that CYP1B1 mRNA expression is increased in female SERTϩ mice. In further support of this, immunoblotting confirmed that CYP1B1 protein expression is also increased in the pulmonary arteries of female SERTϩ mice. Of further interest, both serotonin and 17␤-estradiol stimulation increased CYP1B1 expression in PASMCs. Indeed, similar 17␤-estradiol effects have been previously described in cancer cells (45) . On this evidence, serotonin and 17␤-estradiol may be accountable for increased CYP1B1 expression in female SERTϩ mice.
C/EBP␤ is a transcription factor encoded by the CEBP␤ gene. C/EBP␤ has been previously shown to regulate inflammation, cell differentiation, and cell proliferation (31) . For example, C/EBP␤ is essential in the pathogenesis of multiple proliferative disorders including skin, breast, and ovarian cancer (32, 38, 51) . In line with this, C/EBP␤-deficient mice appear resistant to tumorigenesis (37) . The role of C/EBP␤ in the development of PAH is poorly defined. Increased C/EBP␤ expression has been reported in the lungs of chronically hypoxic rats (42) , where it appears to stimulate inducible nitric oxide synthase expression. Reduced CEBP␤ expression has also been previously reported in the lungs of SERT knockout mice (3) . Conversely, our microarray data show the upregulation CEBP␤ in female SERTϩ mice. Increased CEBP␤ mRNA expression was confirmed by qRT-PCR analysis. We also identified that C/EBP␤ protein expression was increased in the pulmonary arteries of female SERTϩ mice. In support of this, we observed that serotonin and 17␤-estradiol increased C/EBP␤ expression in human PASMCs. These findings suggest that serotonin and 17␤-estradiol may stimulate C/EBP␤ expression in vivo, and this contributes to the pathogenesis of PAH in female SERTϩ mice. We observed increased FOS expression in the pulmonary arteries of female SERTϩ mice. FOS is a proto-oncogene that exists as an immediate early gene transcription factor and is transactivated in response to various stimuli (14) . For example, FOS expression is increased in the heart following exposure to hypoxia (4) . In bovine PASMCs, serotonin is also a potent inducer of FOS expression via a MAPK-dependent pathway (36) . In agreement with this, we observed that serotonin stimulation also increased c-FOS expression in human PASMCs.
Of interest, expression was also increased in 17␤-estradiolstimulated cells. Similar effects have also been described in rat hepatoctyes (19) . In vivo, c-FOS expression is increased in the pulmonary arteries of female SERTϩ mice. Here, our evidence suggests serotonin and 17␤-estradiol stimulate c-FOS expression, and this may be relevant to the pathogenesis of PAH in female SERTϩ mice.
With relevance to human PAH we further examined CEBP␤, CYP1B1, and FOS expression in PASMCs derived from IPAH patients. We observed that expression of these three genes (CEBP␤, CYP1B1 and FOS) was increased in IPAH PASMCs. We observed at least fivefold increases in CEBP␤ and FOS mRNA expression compared with control
PASMCs. Immunoblotting confirmed that the upregulation of C/EBP␤ and c-FOS was also apparent at protein level.
Since these genes are involved in inflammation and proliferation, both of which are essential components in disease pathogenesis (47) , our findings suggest their importance in human PAH. We also observed increased CYP1B1 mRNA and protein expression in IPAH PASMCs, suggesting the importance of CYP1B1-mediated estrogen metabolism in PAH. However, these findings are inconsistent with previous studies in Epstein-Barr virus immortalized B cells derived from female BMPR-II PAH patients (48) , where decreased CYP1B1 mRNA expression was described. Most likely, this is attributable to the differences in cell type investigated. This study focuses on changes in PASMCs, which represent a more physiologically relevant cell type in PAH.
We have previously reported that SERTϩ mice develop elevated RVSP in the absence of RVH (21) . This phenomenon is particular to normoxic mice as we, like others, have shown that mice develop RVH following exposure to hypoxia (18, 22) . We are not alone in observing this phenomenon as other studies have similarly demonstrated elevated RVSP in transgenic mice in the absence of RVH. For example, mice that express BMPR-II R899X in smooth muscle or molecular loss of BMPR-II signaling in smooth muscle demonstrate elevated RVSP with no change in RVH (41, 49) . The observation that this only occurs in normoxic mice suggests that hypoxia induces an effect on RVH that may indeed be independent of RVSP.
The distal arteries are typically those most susceptible to pulmonary vascular remodeling in PAH; however, microarray analysis was performed in the proximal pulmonary arteries of mice as these were the smallest that could be practically dissected out from whole lung. Therefore, these gene changes may not be entirely representative of gene expression changes in smaller resistance arteries. For example, our microarray results show that hypoxic female SERTϩ mice exhibit increased PPAR-␥ expression relative to hypoxic female WT mice. However, previous observations confirm that PPAR-␥ expression is reduced in the distal pulmonary arteries of PAH patients (1), and its targeted deletion in pulmonary artery smooth muscle or endothelial cells is sufficient to cause PAH in mice (7, 11) . This contrast in findings may well result from the effect of hypoxia per se or an indirect compensatory change in response to PAH in SERTϩ mice.
In conclusion, through microarray analysis we have identified a large number of differentially expressed genes in the pulmonary arteries of SERTϩ mice. These findings offer further insight into the gender differences observed in this serotonin-dependent model of PAH. At least three of these genes (CEBP␤, CYP1B1, and FOS) are also upregulated at protein level in these mice. With relevance to human PAH, we identified that mRNA and protein expression of CEBP␤, CYP1B1, and FOS was also increased in PASMCs derived from IPAH patients. This study has described genotypic differences in a serotonin-dependent model of PAH and these findings at least in part, may be relevant to the pathogenesis observed in human PAH.
